loading
前日終値:
$12.94
開ける:
$12.99
24時間の取引高:
730.51K
Relative Volume:
2.57
時価総額:
$657.52M
収益:
$62.02M
当期純損益:
$-45.65M
株価収益率:
-14.29
EPS:
-0.92
ネットキャッシュフロー:
$-9.60M
1週間 パフォーマンス:
+14.15%
1か月 パフォーマンス:
+14.05%
6か月 パフォーマンス:
+36.84%
1年 パフォーマンス:
+59.39%
1日の値動き範囲:
Value
$12.79
$13.25
1週間の範囲:
Value
$11.29
$13.25
52週間の値動き範囲:
Value
$7.88
$13.25

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
名前
Theravance Biopharma Inc
Name
セクター
Healthcare (1157)
Name
電話
650-808-6000
Name
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
職員
97
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
TBPH's Discussions on Twitter

TBPH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TBPH
Theravance Biopharma Inc
13.15 652.18M 62.02M -45.65M -9.60M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
392.79 100.07B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.41 59.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.91 58.03B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
653.83 39.93B 3.06B 1.28B -614.78M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
321.36 36.82B 3.81B -644.79M -669.77M -6.24

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-06 ダウングレード Leerink Partners Outperform → Market Perform
2024-04-12 開始されました BTIG Research Buy
2024-01-08 ダウングレード Evercore ISI Outperform → In-line
2022-05-23 開始されました SVB Leerink Outperform
2021-11-05 アップグレード JP Morgan Underweight → Neutral
2021-09-15 ダウングレード JP Morgan Overweight → Underweight
2021-08-25 ダウングレード Morgan Stanley Overweight → Underweight
2021-08-24 ダウングレード Cowen Outperform → Market Perform
2020-10-14 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-07 開始されました JP Morgan Overweight
2020-06-15 開始されました Morgan Stanley Equal-Weight
2020-05-13 開始されました Cowen Outperform
2020-01-08 繰り返されました H.C. Wainwright Buy
2019-11-06 アップグレード Robert W. Baird Underperform → Neutral
2019-10-29 開始されました H.C. Wainwright Buy
2018-03-29 再開されました Piper Jaffray Overweight
2017-08-17 開始されました Evercore ISI Outperform
2017-06-16 開始されました Cantor Fitzgerald Overweight
2017-05-11 繰り返されました Needham Buy
2016-12-21 開始されました Needham Buy
2016-11-03 開始されました Piper Jaffray Overweight
2016-10-12 ダウングレード Robert W. Baird Neutral → Underperform
2016-08-03 ダウングレード BofA/Merrill Neutral → Underperform
2016-06-20 開始されました Guggenheim Buy
2016-06-20 繰り返されました Leerink Partners Outperform
2016-05-12 開始されました Leerink Partners Outperform
2016-05-05 ダウングレード BofA/Merrill Buy → Neutral
2015-02-03 アップグレード Robert W. Baird Underperform → Neutral
すべてを表示

Theravance Biopharma Inc (TBPH) 最新ニュース

pulisher
Aug 15, 2025

What makes Theravance Biopharma Inc. stock price move sharplyJuly 2025 Snapshot & Short-Term Trading Opportunity Alerts - thegnnews.com

Aug 15, 2025
pulisher
Aug 14, 2025

Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

H.C. Wainwright Sticks to Their Buy Rating for Theravance Biopharma (TBPH) - The Globe and Mail

Aug 14, 2025
pulisher
Aug 14, 2025

The 11% Return This Week Takes Theravance Biopharma's (NASDAQ:TBPH) Shareholders One-year Gains to 51% - 富途牛牛

Aug 14, 2025
pulisher
Aug 14, 2025

Theravance Biopharma Second Quarter 2025 Earnings: EPS Beats Expectations - uk.finance.yahoo.com

Aug 14, 2025
pulisher
Aug 14, 2025

Theravance Biopharma (NASDAQ:TBPH) shareholder returns have been respectable, earning 51% in 1 year - simplywall.st

Aug 14, 2025
pulisher
Aug 13, 2025

Theravance Biopharma, Inc. SEC 10-Q Report - TradingView

Aug 13, 2025
pulisher
Aug 13, 2025

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 13, 2025
pulisher
Aug 13, 2025

Theravance Biopharma stock price target raised to $13 by Leerink Partners By Investing.com - Investing.com Nigeria

Aug 13, 2025
pulisher
Aug 13, 2025

Theravance Biopharma stock price target raised to $13 by Leerink Partners - Investing.com UK

Aug 13, 2025
pulisher
Aug 13, 2025

Theravance Biopharma Q2 2025 Earnings Call Transcript - MarketBeat

Aug 13, 2025
pulisher
Aug 13, 2025

Theravance Biopharma Inc (TBPH) Q2 2025 Earnings Call Highlights: Strong Sales and Strategic ... - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

Theravance Sales Jump 83 Percent - AOL.com

Aug 13, 2025
pulisher
Aug 13, 2025

Theravance anticipates $150M in milestones as CYPRESS trial nears pivotal data readout - MSN

Aug 13, 2025
pulisher
Aug 13, 2025

Technical signs of recovery in Theravance Biopharma Inc. [Analyst Upgrade]Free Safe Entry Momentum Stock Tips - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Theravance Biopharma Reports Strong Q2 2025 Results - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Bio: Q2 Earnings Snapshot - Big Rapids Pioneer

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Sales Jump 83 Percent - The Motley Fool

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Biopharma (TBPH): A High-Conviction Play on Rare Disease Innovation and Durable Cash Flow - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Contradictions Unveiled: Theravance Biopharma's 2025Q2 Earnings Call Highlights Pricing, Strategy, and Market Dynamics - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Biopharma's Q2 Surge: A Case Study in Biotech Resilience and Strategic Precision - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Earnings call transcript: Theravance Biopharma Q2 2025 earnings beat expectations - Investing.com

Aug 12, 2025
pulisher
Aug 12, 2025

What institutional flow reveals about Theravance Biopharma Inc.Trade Safety Matrix for Conservative Traders - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Biopharma Q2 2025 slides: Revenue jumps 22%, cash position triples - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Biopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 12, 2025
pulisher
Aug 12, 2025

THERAVANCE BIOPHARMA Earnings Results: $TBPH Reports Quarterly Earnings - Quiver Quantitative

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Biopharma earnings beat by $0.41, revenue topped estimates - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

Aug 12, 2025
pulisher
Aug 12, 2025

Is Theravance Biopharma Inc. still worth holding after the dipFree Smart Money Tracking Signal Generator - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Technical signs of recovery in Theravance Biopharma Inc.Daily Profit Watch With Forecast Confidence - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Theravance Biopharma Inc.’s volatility index tracking explainedTrend Confirmation Scanner with Entry Focus - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Signal strength of Theravance Biopharma Inc. stock in tech scannersRisk Aware Trading Ideas with Alert Levels - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Real time pattern detection on Theravance Biopharma Inc. stockIntraday Signal Forecast for Fast Traders - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Price momentum metrics for Theravance Biopharma Inc. explainedFree News Based Entry Opportunity Alerts - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Tools to monitor Theravance Biopharma Inc. recovery probabilitySwing Watchlist With Tight Stop Placement - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Using data models to predict Theravance Biopharma Inc. stock movementSmart Stock Forecast Using AI Algorithms - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Theravance Biopharma (TBPH) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Aug 10, 2025
pulisher
Aug 09, 2025

Moving Average Trends for Theravance Biopharma Inc. Stock: What They IndicateTechnical Entry Plan with Risk Minimization - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Theravance Biopharma Inc expected to post earnings of 67 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 07, 2025

Theravance Biopharma Inc. Stock Performance After Earnings: Historical InsightsFree Conservative Entry for High Return Setup - Newser

Aug 07, 2025
pulisher
Aug 04, 2025

How Theravance Biopharma Inc. stock performs during market volatilitySmart Trade Forecast Based on Neural Logic - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Technical Charts Suggest Momentum Shift in Theravance Biopharma Inc.Chart Driven Price Action Analysis - beatles.ru

Aug 04, 2025
pulisher
Aug 03, 2025

What’s the recovery path for long term holders of Theravance Biopharma Inc.Free ROI Boosting Trade Opportunity Calendar - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Theravance Biopharma Inc. stockInvest confidently with professional market insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Theravance Biopharma Inc. stock overvalued or undervaluedInvest confidently with actionable market data - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Theravance Biopharma Inc.Maximize gains with timely market signals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Theravance Biopharma Inc.High-velocity gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Theravance Biopharma Inc. stock compared to the marketBreakthrough profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Theravance Biopharma Inc. stockSuperior returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Theravance Biopharma Inc. stock in 2025Build a diversified portfolio for risk management - Jammu Links News

Aug 03, 2025

Theravance Biopharma Inc (TBPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
大文字化:     |  ボリューム (24 時間):